Download by
Scanning QR Code
No Stock Yet
Loading...
No Stock Yet
No Data
88 Biggest Movers From Yesterday
Gainers Creatd, Inc. (NASDAQ:CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd's board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.Apyx Medical C
61 Stocks Moving In Thursday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ:HCTI) shares gained 46.6% to $0.9824. Healthcare Triangle recently posted a Q1 loss of $0.06 per share.Planet Green Holdings Corp. (NYSE:PLAG) rose 44.6% to $
Shares of several companies in the broader materials sector are trading higher amid overall market strength.
Shares of several companies in the broader materials sector are trading higher amid overall market strength.
Unusually active option classes on open May 26th
Unusual total active option classes on open include: Wendy's (WEN), ArcelorMittal (MT), Amyris (AMRS), Dollar Tree (DLTR), Gores Guggenheim (GGPI), Dollar General (DG), Macy's (M), GameStop (GME), Nik
20 Stocks Moving in Thursday's Pre-Market Session
Gainers TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares rose 51.2% to $0.9603 in pre-market trading after dipping 18% on Wednesday.The Very Good Food Company Inc. (NASDAQ:VGFC) rose 17.1% to $0.3453
Fed Minutes and Incoming Rate Hikes: Analysts Upgrade or Downgrade Amyris, Best Buy, Fisker and More
Markets were relatively flat on Wednesday, as investors wait for what the Federal Reserve has to say about upcoming monetary policy. The Fed is releasing the minutes from its most recent meeting Wedn
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of
Amyris Initiated at Neutral by Piper Sandler
Amyris Initiated at Neutral by Piper Sandler
Amyris Price Target Announced at $2.50/Share by Piper Sandler
Amyris Price Target Announced at $2.50/Share by Piper Sandler
Piper Sandler Starts Amyris at Neutral With $2.50 Price Target
06:50 AM EDT, 05/25/2022 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co